CLS announces poster presentation, describing preclinical work, at SITC 2017, on 8-12 November, in the US
Clinical Laserthermia Systems (CLS) (publ) has received acceptance for its abstract for a poster presentation at this year’s “Society for Immunotherapy of Cancer” (SITC) conference in Maryland, USA. The abstract is titled “Anti-tumor effects and immunological response following immune stimulating interstitial laser thermotherapy” and describes the setup and initial experiences from the preclinical work that CLS has carried out during this year. In parallel with CLS’ commercialization of the TRANBERG®|Thermal Therapy System, the company has also worked to further develop and adjust the